| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.002 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.093 | 0.004 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.085 | 0.008 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.01 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |